{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:55:45Z","timestamp":1787061345043,"version":"build-2736575974"},"reference-count":93,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>During the perioperative period of transplantation, patients experience hypotension secondary to the side effects of anesthesia, surgical stress, inflammatory triggering, and intraoperative fluid shifts, among others causes. Vasopressor support, in this context, must reverse systemic hypotension, but ideally, the agents used should benefit allograft function and avoid the adverse events commonly seen after transplantation. Traditional therapies to reverse hypotension include catecholamine vasopressors (norepinephrine, epinephrine, dopamine, and phenylephrine), but their utility is limited when considering allograft complications and adverse events such as arrhythmias with agents with beta-adrenergic properties. Synthetic angiotensin II (AT2S\u2013[Giapreza]) is a novel vasopressor indicated for distributive shock with a unique mechanism of action as an angiotensin receptor agonist restoring balance to an often-disrupted renin angiotensin aldosterone system. Additionally, AT2S provides a balanced afferent and efferent arteriole vasoconstriction at the level of the kidney and could avoid the arrhythmic complications of a beta-adrenergic agonist. While the data, to date, are limited, AT2S has demonstrated safety in case reports, pilot studies, and small series in the kidney, liver, heart, and lung transplant populations. There are physiologic and hemodynamic reasons why AT2S could be a more utilized agent in these populations, but further investigation is warranted.<\/jats:p>","DOI":"10.3390\/biomedicines12081817","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T05:19:38Z","timestamp":1723439978000},"page":"1817","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Angiotensin II as a Vasopressor for Perioperative Hypotension in Solid Organ Transplant"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8811-2458","authenticated-orcid":false,"given":"Scott T.","family":"Benken","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, University of Illinois Chicago College of Pharmacy, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of Illinois Chicago College of Pharmacy, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin R.","family":"Fraidenburg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois Chicago College of Medicine, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie J.","family":"Benken","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of Illinois Chicago College of Pharmacy, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"ref_1","unstructured":"Giapreza [Package Insert] (2024, July 16). La Jolla Pharmaceuticals. Revised November 2023. Available online: https:\/\/www.giapreza.com."},{"key":"ref_2","unstructured":"Brunton, L.L., and Knollmann, B.r.C. (2023). Goodman & Gilman\u2019s the Pharmacological Basis of Therapeutics, McGraw Hill. [4th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0885066618818460","article-title":"Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin","volume":"35","author":"Rodriguez","year":"2020","journal-title":"J. Intensive Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11906-019-0911-5","article-title":"A Novel Mechanism of Renal Microcirculation Regulation: Connecting Tubule-Glomerular Feedback","volume":"21","author":"Romero","year":"2019","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/phar.2220","article-title":"Vasoactive Agent Use in Septic Shock: Beyond First-Line Recommendations","volume":"39","author":"Sacha","year":"2019","journal-title":"Pharmacotherapy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s11064-018-2679-4","article-title":"ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models","volume":"44","author":"Alenina","year":"2019","journal-title":"Neurochem. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the Treatment of Vasodilatory Shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1097\/TP.0000000000003642","article-title":"Hemodynamic Instability During Liver Transplantation in Patients With End-stage Liver Disease: A Consensus Document from ILTS, LICAGE, and SATA","volume":"105","author":"Bezinover","year":"2021","journal-title":"Transplantation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit. Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e14754","DOI":"10.1111\/ctr.14754","article-title":"Effects of angiotensin II in the management of perioperative hypotension in kidney transplant recipients","volume":"36","author":"Andrews","year":"2022","journal-title":"Clin. Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e5820","DOI":"10.1097\/MD.0000000000005820","article-title":"Risk factors and outcomes associated with a higher use of inotropes in kidney transplant recipients","volume":"96","author":"Choi","year":"2017","journal-title":"Medicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1016\/j.transproceed.2009.08.058","article-title":"Low-dose dopamine in kidney transplantation","volume":"41","author":"Ciapetti","year":"2009","journal-title":"Transplant. Proc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jcrc.2010.02.011","article-title":"A pair analysis of the delayed graft function in kidney recipient: The critical role of the donor","volume":"25","author":"Robert","year":"2010","journal-title":"J. Crit. Care"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/0970-9185.155144","article-title":"Influence of hemodynamics and intra-operative hydration on biochemical outcome of renal transplant recipients","volume":"31","author":"Aulakh","year":"2015","journal-title":"J. Anaesthesiol. Clin. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13613-015-0085-5","article-title":"Personalizing blood pressure management in septic shock","volume":"5","author":"Kato","year":"2015","journal-title":"Ann. Intensive Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.semnephrol.2019.06.006","article-title":"Vasopressor Therapy and Blood Pressure Management in the Setting of Acute Kidney Injury","volume":"39","author":"Busse","year":"2019","journal-title":"Semin. Nephrol."},{"key":"ref_19","first-page":"78","article-title":"Brain death associated ischemia\/reperfusion injury","volume":"9","author":"Pratschke","year":"2004","journal-title":"Ann. Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00000658-200008000-00017","article-title":"Accelerated rejection of renal allografts from brain-dead donors","volume":"232","author":"Pratschke","year":"2000","journal-title":"Ann. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.kint.2018.10.009","article-title":"Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells","volume":"95","author":"Smith","year":"2019","journal-title":"Kidney Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/15269248221087433","article-title":"Perioperative Vasopressors are Associated with Delayed Graft Function in Kidney Transplant Recipients in a Primarily Black and Hispanic Cohort","volume":"32","author":"Benken","year":"2022","journal-title":"Prog. Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jamcollsurg.2014.01.058","article-title":"Efficacy and safety of phenylephrine in the management of low systolic blood pressure after renal transplantation","volume":"218","author":"Day","year":"2014","journal-title":"J. Am. Coll. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1053\/j.ajkd.2019.09.003","article-title":"US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States","volume":"75","author":"Saran","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Chappell, M.C. (2019). The Angiotensin-(1-7) Axis: Formation and Metabolism Pathways. Angiotensin-(1-7), Springer.","DOI":"10.1007\/978-3-030-22696-1_1"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/nep.13467","article-title":"Role of renin-angiotensin system in acute kidney injury-chronic kidney disease transition","volume":"23","author":"Chou","year":"2018","journal-title":"Nephrology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/petr.12712","article-title":"Sex differences in renin response and changes of capillary diameters after renal ischemia\/reperfusion injury","volume":"20","author":"Csohany","year":"2016","journal-title":"Pediatr. Transplant."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0041-1345(00)02479-9","article-title":"Influence of brain death on cytokine release in organ donors and renal transplants","volume":"33","author":"Stangl","year":"2001","journal-title":"Transplant. Proc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"826240","DOI":"10.1155\/2010\/826240","article-title":"Innate pathways of immune activation in transplantation","volume":"2010","author":"Brennan","year":"2010","journal-title":"J. Transplant."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00007890-199902150-00001","article-title":"Brain death and its influence on donor organ quality and outcome after transplantation","volume":"67","author":"Pratschke","year":"1999","journal-title":"Transplantation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1213\/XAA.0000000000000775","article-title":"When All Else Fails: Novel Use of Angiotensin II for Vasodilatory Shock: A Case Report","volume":"11","author":"Chow","year":"2018","journal-title":"A&A Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/j.1600-6143.2010.03179.x","article-title":"A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation","volume":"10","author":"Irish","year":"2010","journal-title":"Am. J. Transplant."},{"key":"ref_33","first-page":"681","article-title":"Efficacy and Safety of Angiotensin II Compared to Catecholamine Vasopressors as a First-Line Vasopressor for Perioperative Hypotension in Kidney Transplant Recipients","volume":"22","author":"Urias","year":"2022","journal-title":"Am. J. Transplant."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Beltran, L., Benken, J., Jou, J., Benedetti, E., Nishioka, H., Alamreia, E., Belcher, R., and Benken, S. (2024). Efficacy and safety of perioperative angiotensin II versus phenylephrine as a first-line continuous infusion vasopressor in kidney transplant recipients. Clin. Transplant., accepted, in production.","DOI":"10.1111\/ctr.15432"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"E214","DOI":"10.1161\/CIR.0000000000000905","article-title":"Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association","volume":"142","author":"Tisdale","year":"2020","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1034\/j.1600-6143.2003.00071.x","article-title":"Hospitalized atrial fibrillation after renal transplantation in the United States","volume":"3","author":"Abbott","year":"2003","journal-title":"Am. J. Transplant."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2215\/CJN.00920805","article-title":"Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation","volume":"1","author":"Lentine","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1164\/rccm.200701-031OC","article-title":"Incidence and Prognosis of Sustained Arrhythmias in Critically Ill Patients","volume":"178","author":"Annane","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"326.e1","DOI":"10.1016\/j.jcrc.2011.10.011","article-title":"Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients","volume":"27","author":"Kanji","year":"2012","journal-title":"J. Crit. Care"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1097\/CCM.0000000000001166","article-title":"Atrial Fibrillation Is an Independent Predictor of Mortality in Critically Ill Patients","volume":"43","author":"Shaver","year":"2015","journal-title":"Crit. Care Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.anclin.2017.04.006","article-title":"Anesthesia for Liver Transplantation","volume":"35","author":"Adelmann","year":"2017","journal-title":"Anesthesiol. Clin."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1213\/ANE.0000000000004343","article-title":"Reversal of Vasodilatory Shock: Current Perspectives on Conventional, Rescue, and Emerging Vasoactive Agents for the Treatment of Shock","volume":"130","author":"Chow","year":"2020","journal-title":"Anesth. Analg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1053\/j.jvca.2017.10.032","article-title":"Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy","volume":"32","author":"Shaefi","year":"2018","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Deng, J., Li, L., Feng, Y., and Yang, J. (2023). Comprehensive Management of Blood Pressure in Patients with Septic AKI. J. Clin. Med., 12.","DOI":"10.3390\/jcm12031018"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of Dopamine and Norepinephrine in the Treatment of Shock","volume":"362","author":"Biston","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","article-title":"A comparison of epinephrine and norepinephrine in critically ill patients","volume":"34","author":"Myburgh","year":"2008","journal-title":"Intensiv. Care Med."},{"key":"ref_48","first-page":"F274","article-title":"Renal microvascular effects of vasopressin and vasopressin antagonists","volume":"256","author":"Edwards","year":"1989","journal-title":"Am. J. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/cc8224","article-title":"Bench-to-bedside review: Vasopressin in the management of septic shock","volume":"15","author":"Russell","year":"2009","journal-title":"Crit. Care"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/ajt.14736","article-title":"Case report of high-dose hydroxocobalamin in the treatment of vasoplegic syndrome during liver transplantation","volume":"18","author":"An","year":"2018","journal-title":"Am. J. Transplant."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13054-023-04397-7","article-title":"Early adjunctive methylene blue in patients with septic shock: A randomized controlled trial","volume":"27","author":"Kattan","year":"2023","journal-title":"Crit. Care"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.chest.2022.09.021","article-title":"High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic Shock","volume":"163","author":"Patel","year":"2022","journal-title":"Chest"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e078713","DOI":"10.1136\/bmjopen-2023-078713","article-title":"Angiotensin II in liver transplantation (AngLT-1): Protocol of a randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bokoch","year":"2023","journal-title":"BMJ Open"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1097\/TP.0000000000003331","article-title":"The Association Between Vena Cava Implantation Technique and Acute Kidney Injury After Liver Transplantation","volume":"104","author":"Hannon","year":"2020","journal-title":"Transplantation"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/bja\/aeu556","article-title":"Acute kidney injury following orthotopic liver transplantation: Incidence, risk factors, and effects on patient and graft outcomes","volume":"114","author":"Hilmi","year":"2015","journal-title":"Br. J. Anaesth."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1016\/j.transproceed.2014.09.161","article-title":"Comparison of RIFLE and AKIN criteria in the evaluation of the frequency of acute kidney injury in post-liver transplantation patients","volume":"46","author":"Karapanagiotou","year":"2014","journal-title":"Transplant. Proc."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Casey, S., Schierwagen, R., Mak, K.Y., Klein, S., Uschner, F., Jansen, C., Praktiknjo, M., Meyer, C., Thomas, D., and Herath, C. (2019). Activation of the Alternate Renin-Angiotensin System Correlates with the Clinical Status in Human Cirrhosis and Corrects Post Liver Transplantation. J. Clin. Med., 8.","DOI":"10.3390\/jcm8040419"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3904\/kjim.2017.317","article-title":"Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension","volume":"33","author":"Shim","year":"2018","journal-title":"Korean J. Intern. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.gastro.2013.06.036","article-title":"Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis","volume":"145","author":"Grace","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1053\/jhep.2002.31352","article-title":"Change in portal flow after liver transplantation: Effect on hepatic arterial resistance indices and role of spleen size","volume":"35","author":"Bolognesi","year":"2002","journal-title":"Hepatology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e01402","DOI":"10.1213\/XAA.0000000000001402","article-title":"Intraoperative Use of Angiotensin II for Severe Vasodilatory Shock During Liver Transplantation: A Case Report","volume":"15","author":"Running","year":"2021","journal-title":"A&A Pract."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1053\/j.jvca.2019.03.054","article-title":"Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion Physiology","volume":"33","author":"Wieruszewski","year":"2019","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.CIR.25.1.263","article-title":"Adjunctive use of a biologic pressor agent, angiotensin, in management of shock","volume":"25","author":"Derrick","year":"1962","journal-title":"Circulation"},{"key":"ref_65","first-page":"333","article-title":"Increased plasma angiotensinogen in cardiac transplantation patients","volume":"2","author":"Metsarinne","year":"1993","journal-title":"Eur. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0888-6296(90)90046-I","article-title":"Low systemic vascular resistance during cardiac surgery: Case reports, brief review, and management with angiotensin II","volume":"4","author":"Thaker","year":"1990","journal-title":"J. Cardiothorac. Anesth."},{"key":"ref_67","first-page":"532","article-title":"Incidence and predictors of vasoplegia after heart failure surgery","volume":"51","author":"Palmen","year":"2017","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13054-020-2743-8","article-title":"Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options","volume":"24","author":"Busse","year":"2020","journal-title":"Crit. Care"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/icvts\/ivy352","article-title":"Risk factors for vasoplegia after cardiac surgery: A meta-analysis","volume":"28","author":"Dayan","year":"2019","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0022-5223(98)70049-2","article-title":"Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent","volume":"116","author":"Argenziano","year":"1998","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.jvca.2020.08.001","article-title":"Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study","volume":"35","author":"Klijian","year":"2021","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1053\/j.jvca.2020.07.087","article-title":"Angiotensin II for Critically Ill Patients With Shock After Heart Transplant","volume":"35","author":"Cutler","year":"2021","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.athoracsur.2018.11.047","article-title":"Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome","volume":"108","author":"Evans","year":"2019","journal-title":"Ann. Thorac. Surg."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1053\/j.jvca.2019.03.004","article-title":"Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock","volume":"33","author":"Wieruszewski","year":"2019","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"98","DOI":"10.14797\/mdcvj.576","article-title":"Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting","volume":"17","author":"Sovic","year":"2021","journal-title":"Methodist Debakey Cardiovasc. J."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","article-title":"Angiotensin II Infusion for Shock","volume":"159","author":"Wieruszewski","year":"2020","journal-title":"Chest"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Johnson, A.J., Tidwell, W., McRae, A., Henson, C.P., and Hernandez, A. (2023). Angiotensin-II for vasoplegia following cardiac surgery. Perfusion, 02676591231215920.","DOI":"10.1177\/02676591231215920"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/anae.15802","article-title":"A double-blind randomised feasibility trial of angiotensin-2 in cardiac surgery","volume":"77","author":"Coulson","year":"2022","journal-title":"Anaesthesia"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.HYP.34.5.1053","article-title":"Angiotensin II stimulates gene expression of cardiac insulin-like growth factor I and its receptor through effects on blood pressure and food intake","volume":"34","author":"Brink","year":"1999","journal-title":"Hypertension"},{"key":"ref_80","first-page":"H238","article-title":"Angiotensin II increases cardiac protein synthesis in adult rat heart","volume":"265","author":"Geenen","year":"1993","journal-title":"Am. J. Physiol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Verma, K., Pant, M., Paliwal, S., Dwivedi, J., and Sharma, S. (2021). An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.734917"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jama.2015.1175","article-title":"Single- vs double-lung transplantation in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis since the implementation of lung allocation based on medical need","volume":"313","author":"Schaffer","year":"2015","journal-title":"JAMA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.1016\/j.ajt.2024.01.017","article-title":"OPTN\/SRTR 2022 Annual Data Report: Lung","volume":"24","author":"Valapour","year":"2024","journal-title":"Am. J. Transplant."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13069-015-0023-z","article-title":"Modulation of angiotensin II signaling in the prevention of fibrosis","volume":"8","author":"Murphy","year":"2015","journal-title":"Fibrogenesis Tissue Repair."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Wang, J., Chen, L., Chen, B., Meliton, A., Liu, S.Q., Shi, Y., Liu, T., Deb, D.K., Solway, J., and Li, Y.C. (2015). Chronic Activation of the Renin-Angiotensin System Induces Lung Fibrosis. Sci. Rep., 5.","DOI":"10.1038\/srep15561"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2002975","DOI":"10.1183\/13993003.02975-2020","article-title":"Association between the renin\u2013angiotensin system and chronic lung allograft dysfunction","volume":"58","author":"Berra","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00408-014-9588-3","article-title":"Angiotensin receptors as sensitive markers of acute bronchiole injury after lung transplantation","volume":"192","author":"Nataatmadja","year":"2014","journal-title":"Lung"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e14022","DOI":"10.1111\/ctr.14022","article-title":"Financial impact of delayed graft function in kidney transplantation","volume":"34","author":"Kim","year":"2020","journal-title":"Clin. Transplant."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.athoracsur.2014.07.035","article-title":"Postoperative atrial fibrillation impacts on costs and one-year clinical outcomes: The Veterans Affairs Randomized On\/Off Bypass Trial","volume":"99","author":"Almassi","year":"2015","journal-title":"Ann. Thorac. Surg."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/00185787221130229","article-title":"Extended Stability of Vasopressin Injection in Polyvinyl Chloride Bags and Polypropylene Syringes and Its Impact on Critically Ill Patient Care and Medication Waste","volume":"58","author":"Rice","year":"2023","journal-title":"Hosp. Pharm."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/00185787231206525","article-title":"Characterizing the Stability of Angiotensin II in 0.9% Sodium Chloride Using High Performance Liquid Chromatography and Liquid Chromatography Tandem Mass Spectrometry","volume":"59","author":"Belcher","year":"2024","journal-title":"Hosp. Pharm."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1089253220949070","article-title":"Treatment of Renin-Angiotensin-Aldosterone System Dysfunction With Angiotensin II in High-Renin Septic Shock","volume":"25","author":"Chow","year":"2021","journal-title":"Semin. Cardiothorac. Vasc. Anesth."},{"key":"ref_93","first-page":"1002","article-title":"The Association Between Angiotensin II and Renin Kinetics in Patients After Cardiac Surgery","volume":"134","author":"Meersch","year":"2022","journal-title":"Anesth. Analg."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/8\/1817\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:34:14Z","timestamp":1760110454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/8\/1817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":93,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["biomedicines12081817"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines12081817","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]}}}